SME Times is powered by   
Search News
Just in:   • E-commerce, social media firms must erase inactive user data after 3 years: DPDP Act  • Trump administration sues California over voter-approved Prop 50  • Adani to invest Rs 63,000 crore for two energy projects in Assam, generate thousands of jobs  • India and Russia to deepen trade ties, unlock market access  • Bihar results: EC trends show NDA’s decisive lead over grand alliance, JD(U) soars to top spot 
Last updated: 22 Jan, 2021  

Vaccine.Thmb.jpg SL grants approval for Oxford-AstraZeneca vaccine's emergency use

Vaccine.jpg
   Top Stories
» E-commerce, social media firms must erase inactive user data after 3 years: DPDP Act
» Adani to invest Rs 63,000 crore for two energy projects in Assam, generate thousands of jobs
» Latest Cabinet decisions to ensure global competitiveness, boost self-reliance: PM Modi
» Sensex, Nifty open in green over US-India trade talks, Bihar exit polls
» India, Chile agree to bolster trade, health and defence ties
IANS | 22 Jan, 2021
Sri Lankan authorities on Friday granted approval for the emergency use of the Oxford-AstraZeneca Covid-19 vaccine, Minister for Pharmaceutical Production and Regulation Channa Jayasumana said.

Jayasumana said the National Medicines Regulatory Authority (NMRA) had granted the approval for the emergency use of the British vaccine while several other vaccines were also in the pipeline at the National Medicines Regulatory Authority, reports Xinhua news agency.

This the first time Sri Lanka has approved a vaccine for emergency use.

State Minister of Primary Health Care, Epidemics and Covid-19 Disease Control Sudarshani Fernandopulle said the vaccine will be imported to Sri Lanka by mid-February.

She said Sri Lanka will get 20 per cent of the population covered by the World Health Organization, while for another 30 per cent of the population, the government will purchase a vaccine.

"Our intention is to cover at least 50 per cent of the population," Fernandopulle said.

Sri Lanka has to date recorded over 56,000 Covid-19 patients and recorded 276 deaths.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹88.70
₹87
UK Pound
₹119.90
₹116
Euro
₹104.25
₹100.65
Japanese Yen ₹59.20 ₹57.30
As on 30 Oct, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter